A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia

American Journal of Obstetrics and Gynecology
I MilsomG Rybo


Treatment with flurbiprofen (100 mg twice a day for 5 days), tranexamic acid (1.5 gm three times a day for 3 days and 1 gm twice a day for another 2 days), and an intrauterine contraceptive device releasing 20 micrograms levonorgestrel per day was compared in women with idiopathic menorrhagia. The menstrual blood loss during two control periods in 15 women subsequently treated with flurbiprofen and tranexamic acid was 295 +/- 52 ml and 203 +/- 25.2 ml in the 16 women later fitted with a levonorgestrel-releasing intrauterine contraceptive device. Menstrual blood loss was reduced by all three forms of treatment. The reduction in menstrual blood loss expressed as a percentage of the mean of two control cycles for each form of treatment was as follows: flurbiprofen, 20.7% +/- 9.9%; tranexamic acid, 44.4% +/- 8.3%; levonorgestrel-releasing intrauterine contraceptive device after 3 months, 81.6% +/- 4.5%; levonorgestrel-releasing intrauterine contraceptive device after 6 months, 88.0% +/- 3.1%; levonorgestrel-releasing intrauterine contraceptive device after 12 months, 95.8% +/- 1.2%. The reduction in menstrual blood loss achieved by the levonorgestrel-releasing intrauterine contraceptive device was greater than that recorded with fl...Continue Reading

Associated Clinical Trials

Sep 22, 2016·Magdy Milad, MD


Dec 1, 1990·British Journal of Obstetrics and Gynaecology·L Birgerson, R Bright-Paul
Jan 1, 1988·Acta Obstetricia Et Gynecologica Scandinavica·B AnderschG Rybo
Jan 1, 1966·Acta Obstetricia Et Gynecologica Scandinavica·G Rybo
Jul 1, 1984·British Journal of Obstetrics and Gynaecology·M C ReesA C Turnbull
Mar 1, 1983·British Journal of Obstetrics and Gynaecology·A Bergqvist, G Rybo
Jan 1, 1964·Scandinavian Journal of Clinical and Laboratory Investigation·L HALLBERG, L NILSSON

❮ Previous
Next ❯


Jul 9, 2013·Journal of Mid-life Health·Osama ShawkiNavneet Magon
Jul 15, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·O Graesslin, E Derniaux
Mar 1, 2002·Human Reproduction·S HagueMargaret C P Rees
Jul 16, 2014·Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine·Oded GiladGil Klinger
Sep 1, 2005·Women's Health·Regine Sitruk-Ware, Pirjo Inki
Mar 1, 1995·British Journal of Pharmacology·T J Gelety, G Chaudhuri
Oct 14, 2011·Journal of General Internal Medicine·Judith M E WalshEleanor Bimla Schwarz
Jan 7, 2015·Thrombosis Research·Lilian TengbornErik Berntorp
Oct 3, 2015·Pediatric Annals·Tanya L Kowalczyk MullinsEric S Mullins
Feb 7, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Zara Haider, Rachel D'Souza
Dec 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·I S Fraser
Sep 16, 2009·The Journal of Obstetrics and Gynaecology Research·Alka KriplaniNutan Agarwal
Feb 24, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Rajmohan GopimohanAbi S Aprem
Sep 9, 2005·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·B SharmaC Ray
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·G P Acharya, A M Mills
Dec 25, 2009·American Journal of Obstetrics and Gynecology·Maria Isabel RodriguezPhilip D Darney
Nov 3, 2010·American Journal of Obstetrics and Gynecology·Oskari HeikinheimoJorma Paavonen
Sep 1, 1996·American Journal of Obstetrics and Gynecology·C J Chuong, P F Brenner
Apr 11, 2015·Journal of Mid-life Health·Pallavi C DhamangaonkarArchana Saxena
Sep 11, 2012·Current Problems in Pediatric and Adolescent Health Care·Lauren B HartmanLoris Y Hwang
May 29, 2007·Contraception·Paivi Pakarinen, Tapani Luukkainen
Aug 17, 2010·Taiwanese Journal of Obstetrics & Gynecology·Fu-Shaing PengYu-Shih Yang
Oct 31, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A KriplaniS Diwakar
Jan 1, 1995·International Journal of Technology Assessment in Health Care·A CoulterM C Rees
May 1, 1995·British Journal of Obstetrics and Gynaecology·J T PrestonS K Smith
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·C Kremer, S Duffy
Aug 27, 2005·Obstetrical & Gynecological Survey·Jeffrey T Jensen
May 22, 2007·Clinical Obstetrics and Gynecology·Malcolm G Munro
Jun 30, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ray Garry
May 1, 1997·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M ColemanC Farquhar
Mar 21, 2007·Obstetrical & Gynecological Survey·Anita L Nelson, Stephanie B Teal
Jan 9, 2017·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Sukhbir SinghWendy Lynn Wolfman
May 14, 2014·Reproductive Sciences·Leo DohertyHugh Taylor
Jul 20, 2012·The Annals of Pharmacotherapy·Sandra L Hrometz
Apr 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·R F Valle
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·Y L OngE E Mayne

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.